JONES WILLIAM A JR 4
4 · NewAmsterdam Pharma Co N.V. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
JONES WILLIAM A JR
Chief Commercial Officer
Transactions
- Award
Ordinary Shares
2025-01-07+43,000→ 43,000 total
Footnotes (2)
- [F1]Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date.
- [F2]Each RSU was granted on January 7, 2025 for no consideration.